If Medtronic’s troubling Q4 report offers a snapshot of a company hit hard by COVID-19, the next image in the sequence may show a faster-than-expected recovery and increased merger-and-acquisition of smaller companies. In the quarterly call on Thursday morning, Medtronic CEO Geoff Martha and CFO Karen Parkhill expressed optimism that the company’s businesses already are […]
How do medtech investors, CEOs manage portfolio companies going forward?
In Episode 10 of DeviceTalks Weekly, we talk with two successful starters of medtech companies about how they’re building and maintaining their medtech portfolios during this pandemic landscape. Our guests this week are Dr. Justin Klein, managing partner of Vensana Capital, and Duke Rohlen, chair of Ajax Health. Together, Klein and Rohlen have created, backed and sold […]
Medtech startups rack up strong VC totals in Q1, but future uncertain, SVB says
Medtech startups raising venture capital in the first quarter kept the strong pace from 2019, according to an analysis by Silicon Valley Bank. But the uncertainty over the pandemic likely will slow down fund-raising in the second quarter. In an interview with DeviceTalks Weekly Podcast, Jonathan Norris, managing director, SVB Life Sciences, says SVB recorded […]
Smile Direct Club aligners now available in-office; stock soars
SmileDirectClub (NSDQ:SDC) shares skyrocketed following the announcement that its clear aligners are set to be offered through the wholesale channel in dentist and orthodontist offices. The Nashville, Tenn.-based company’s announcement follows the Dec. 31, 2019, expiration of its exclusive supply agreement with Align Technology (NSDQ:ALGN). After yesterday’s announcement, shares of SDC are up 16.24% at $13.60 per […]
Report: Ambulatory surgery centers will shake up medtech
An increase in the number of surgical procedures taking place at ambulatory care centers could change the playing field for medtech companies, according to a new report by Bain & Co. The management consulting firm predicted that procedures at these stand-alone centers could grow by 6% to 7% annually through 2021, with orthopedic, spine and […]
How can medical device companies thrive in the future?
Medical device data is becoming more important than the hardware itself, so medtech companies need to forge a partnership with consumer technology companies to stay innovative, according to a new report from Deloitte. The Deloitte report — called “Winning the Future of Medtech” — came out yesterday in advance of next week’s AdvaMed MedTech Conference […]
Here’s how precision medicine could change medical imaging
The business of precision medical imaging is poised to take off in the next few years, according to a new analysis by Frost & Sullivan. The market research firm’s report, “Growth Opportunities in Precision Medical Imaging, Forecast to 2022,” said new technologies and processes in diagnostic and therapeutic imaging could spur the market to grow […]
Here are the top 5 medtech stories of mid-2018
A growing U.S. trade war with China and other countries casts a pall on medtech — and U.S. business in general — in mid-2018. The landscape of the medical device industry continues to evolve, though. There’s a major corporate spinout in the works, as well as a mega-merger that apparently was not to be. Read […]
China wants to dominate medtech: Here’s how
Under its “Made in China 2025” plan, the Chinese government seeks explosive growth in biomedical and high-end medical device manufacturing. Grace Fu Palma, China Med Device In 2015, the China State Council issued a 10-year manufacturing plan called “Made in China 2025.” The goal is to elevate the “giant but weak” Chinese manufacturing industry into […]
How artificial life spawned a billion-dollar industry
(Reuters) – Scientists are getting closer to building life from scratch and technology pioneers are taking notice, with record sums moving into a field that could deliver novel drugs, materials, chemicals and even perfumes. Despite ethical and safety concerns, investors are attracted by synthetic biology’s wide market potential and the plummeting cost of DNA synthesis, […]
Bristol-Myers Squibb, Enterome ink immuno-oncology collab
Bristol-Myers Squibb (NYSE:BMY) said today that it inked a collaboration agreement with Enterome to discover and develop microbiome-derived biomarkers and drug targets as potential companion diagnostics and therapeutics for cancer. According to the agreement, Bristol-Myers Squibb will be given exclusive rights to intellectual property and therapies that result from the collaboration. Enterome will get an […]
- 1
- 2
- 3
- …
- 24
- Next Page »
